Skip to Main Content

Paper Details

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.
Nat Commun
18
2022
CDKN2A, CSMD3, CUP, FGFR2, KRAS, LRP1B, MUC16, TP53, cancer, cancer of unknown primary, cancer-related genes, exome, genome, patients

Datasets

Release 1.2